A detailed history of Nemes Rush Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nemes Rush Group LLC holds 51,269 shares of JNJ stock, worth $7.95 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
51,269
Previous 49,098 4.42%
Holding current value
$7.95 Million
Previous $7.77 Billion 3.52%
% of portfolio
1.03%
Previous 1.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$144.38 - $157.78 $313,448 - $342,540
2,171 Added 4.42%
51,269 $7.49 Billion
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $782,774 - $820,697
-5,043 Reduced 9.31%
49,098 $7.77 Billion
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $588,078 - $641,716
-4,039 Reduced 6.94%
54,141 $8.49 Billion
Q3 2023

Nov 09, 2023

BUY
$155.75 - $174.48 $285,489 - $319,821
1,833 Added 3.25%
58,180 $9.06 Billion
Q2 2023

Aug 02, 2023

BUY
$154.35 - $166.11 $8.7 Million - $9.36 Million
56,347 New
56,347 $9.33 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.